Futurewell Pharmaceuticals Private Limited
About Futurewell Pharmaceuticals Private Limited
Data last updated:
Futurewell Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 13 January 2023.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2023PTC259827.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sudha Jha Nandi and Dipankar Shome.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2024, the company reported a revenue of ₹37.89 Lakh. For the same year it recorded a net profit of ₹58,792 (net margin 1.6%) and EBITDA of ₹1.11 Lakh (EBITDA margin 2.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Futurewell Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal.
- Registered Address75 Ajay Nagar Ground Floor 2nd Road, P.O. Santoshpur P.S. Purba Jadavpur, Kolkata, West Bengal, India – 700075
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Futurewell Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Futurewell Pharmaceuticals Private Limited, buy the company report.
Financials of Futurewell Pharmaceuticals Private Limited
FY 2024 filings availableFuturewell Pharmaceuticals Private Limited reported revenue of ₹37.89 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹1.11 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹58,792 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.9% | |
| Net Profit Margin | 1.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Futurewell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Futurewell Pharmaceuticals Private Limited
Futurewell Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudha Jha Nandi | Director | 13 Jan 2023 | 3 Years 9 Months | Current |
| Dipankar Shome | Director | 05 Feb 2026 | 0 Years 8 Months | Current |
Peer comparison
Futurewell Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VM Homoeo Source Private Limited | ₹38.07 Lakh (FY 2023) | 336.0% | New Delhi, Delhi, India | |||
| Maxicure Pharma Private Limited | ₹37.99 Lakh (FY 2024) | 39.0% | Bangalore, Karnataka, India | |||
| Pentaproud Pharmaceuticals Private Limited | ₹37.93 Lakh (FY 2025) | -23.0% | Kochi, Kerala, India | |||
| Futurewell Pharmaceuticals Private Limitedthis company | ₹37.89 Lakh (FY 2024) | ₹58,792 | 1.6% | Kolkata, West Bengal, India | ||
| Himcure Pharmaceuticals Private Limited | ₹37.86 Lakh (FY 2024) | 22.0% | Rampur, Uttar Pradesh, India |
To see the full peer comparison of Futurewell Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Futurewell Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Futurewell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Futurewell Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Futurewell Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Dipankar Shome was appointed as Director on 05 Feb 2026.
Frequently asked questions
Futurewell Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 13 January 2023 (3+ years old) and is registered under CIN U24100WB2023PTC259827.
Futurewell Pharmaceuticals has 2 current directors:
- Sudha Jha Nandi - Director
- Dipankar Shome - Director
The latest financial statements of Futurewell Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Futurewell Pharmaceuticals is U24100WB2023PTC259827. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Futurewell Pharmaceuticals was incorporated on 13 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Futurewell Pharmaceuticals by revenue are VM Homoeo Source Private Limited, Maxicure Pharma Private Limited, Pentaproud Pharmaceuticals Private Limited, Himcure Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Dipankar Shome was appointed as Director on 05 Feb 2026. Kumaresh Nandi was appointed as Director on 13 Jan 2023. Sudha Jha Nandi was appointed as Director on 13 Jan 2023.
The registered office of Futurewell Pharmaceuticals is at 75 Ajay Nagar Ground Floor 2nd Road, P.O. Santoshpur P.S. Purba Jadavpur, Kolkata, West Bengal, India – 700075.
Futurewell Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Futurewell Pharmaceuticals is compliant as of 05 July 2026. The company is actively filing with the Registrar of Companies.
Futurewell Pharmaceuticals can be reached at its registered office: 75 Ajay Nagar Ground Floor 2nd Road, P.O. Santoshpur P.S. Purba Jadavpur, Kolkata, West Bengal, India – 700075.